1. Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2
    Xiaowei Zheng et al, 2015, Cancer Biology & Therapy CrossRef
  2. Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer
    SI-YING CHEN et al, 2016 CrossRef
  3. Data from a comparative proteomic analysis of tumor-derived lung-cancer CD105(+) endothelial cells.
    Huifang Peng, 0 CrossRef
  4. Contribution of nucleophosmin overexpression to multidrug resistance in breast carcinoma
    Siying Chen et al, 2018, Journal of Drug Targeting CrossRef
  5. Methylcrotonoyl-CoA carboxylase 2 overexpression predicts an unfavorable prognosis and promotes cell proliferation in breast cancer
    Yu Liu et al, 2019, Biomarkers in Medicine CrossRef
  6. Could polymorphisms in ABCB1 gene represent a genetic risk factor for the development of mammary tumors in dogs?
    T. Maués et al, 2019, The Veterinary Journal CrossRef
  7. Comparative proteomics analysis of differential proteins in respond to doxorubicin resistance in myelogenous leukemia cell lines
    Shi Qinghong et al, 2015, Proteome Sci CrossRef
  8. Identification and verification of transgelin-2 as a potential biomarker of tumor-derived lung-cancer endothelial cells by comparative proteomics.
    Huifang Peng, 0 CrossRef
  9. Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer
    P. S. Thakur et al, 2016, J Cancer Res Clin Oncol CrossRef
  10. Quantitative proteomic analysis identifies novel regulators of methotrexate resistance in choriocarcinoma
    Fu Jun et al, 2020, Gynecologic Oncology CrossRef
  11. Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer
    Xiaoling Qian et al, 2017, Oncotarget CrossRef
  12. Probing the methotrexate–protein interactions by proteomics and thermostability assay for drug resistance study
    Wenbo Zhang et al, 2021, Anal. Methods CrossRef
  13. Proteomics Approach of Rapamycin Anti-Tumoral Effect on Primary and Metastatic Canine Mammary Tumor Cells In Vitro
    Patrícia F. Lainetti et al, 2021, Molecules CrossRef
  14. miRNome of inflammatory breast cancer
    Diana V Maltseva et al, 2014, BMC Res Notes CrossRef
  15. Identification and Characterization of Immunogene-Related Alternative Splicing Patterns and Tumor Microenvironment Infiltration Patterns in Breast Cancer
    Shuang Guo et al, 2022, Cancers CrossRef
  16. Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach
    Nelson C. Soares et al, 2022, Journal of Proteomics CrossRef
  17. Targeting PGAM1 in cancer: An emerging therapeutic opportunity.
    Guan-Jun Yang et al, 2022, Eur J Med Chem CrossRef
  18. PSMA2 knockdown impacts expression of proteins involved in immune and cellular stress responses in human lung cells
    Mahamud-ur Rashid et al, 2022, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  19. Cluster of resistance-inducing genes in MCF-7 cells by estrogen, insulin, methotrexate and tamoxifen extracted via NMF
    Angelina Boccarelli et al, 2023, Pathology - Research and Practice CrossRef
  20. Role of identified proteins in the proteome profiles of CDK4/6 inhibitor-resistant breast cancer cell lines
    Binayak Kumar et al, 2023, Mol. Omics CrossRef
  21. Efficient delivery of methotrexate to MDA-MB-231 breast cancer cells by a pH-responsive ZnO nanocarrier
    Jiko Raut et al, 2023, Sci Rep CrossRef
  22. Efficient PEGylated Dendrimer Nanoplatform for Codelivery of Hyaluronidase and Methotrexate: A New Frontier in Chemotherapeutic Efficacy and Tumor Penetration
    Asieh Soozanipour et al, 2024, ACS Appl. Nano Mater. CrossRef
  23. Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics
    Mingjie Zou et al, 2024, Biology CrossRef
  24. Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections
    Maura Rojas-Pirela et al, 2025, Open Biol. CrossRef